A7R011 (LAEA), transverse colon, section 8, 5d post-ATI
source_name
Transverse colon
tissue
Transverse colon
treatment
LAEA group (persistent reservoir model): challenged intravenously with a 300 TCID50 dose of barcoded SIVmac239M2; suppressive ART initiated at week 10 post-challenge and maintained for 382 days (~12 months) before analytical treatment interruption (ATI); necropsied 5 days post-ATI, during the pre-viremic eclipse phase.
batch
A7R011
tissue preservation_method
fresh frozen, optimal cutting temperature (OCT) compound
slide parameters
V12-N14-007 C1
geo_loc_name
missing
collection_date
missing